5PSQ-029 Evaluation of the efficacy and safety of erenumab in the prophylaxis of chronic and episodic migraine

Autor:	AM Martínez Soto, M García Coronel, C Pastor Mondéjar, JM Marco Puig, P Ortiz Fernandez, P Fernández-Villacañas Fernández, C Caballero Requejo, L Rentero Redondo, C Iniesta Navalón, I Salar Valverde, E Urbieta Sanz
Rok vydání:	2022
Zdroj:	Section 5: Patient safety and quality assurance.
DOI:	10.1136/ejhpharm-2022-eahp.266
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a51dea737afaa4f49a67ad656cbd514e https://doi.org/10.1136/ejhpharm-2022-eahp.266 Zobrazit plný text záznamu